Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-17

Clinical Trial Update: Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of Clostridium butyricum on irritable bowel syndrome; current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clostridium butyricum (Clostridium butyricum)

Snippet

Sponsor: Shandong University | Conditions: Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome | Phase 4 | Status: UNKNOWN